Catalent
CTLT
#1737
Rank
NZ$19.94 B
Marketcap
NZ$109.88
Share price
0.00%
Change (1 day)
15.86%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Cash on Hand

Cash on Hand as of September 2024 : NZ$0.57 Billion

According to Catalent's latest financial reports the company has NZ$0.57 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Catalent - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-06-30NZ$0.45 B-47.05%
2022-06-30NZ$0.86 B-37.62%
2021-06-30NZ$1.38 B-6.44%
2020-06-30NZ$1.47 B187.55%
2019-06-30NZ$0.51 B-15.18%
2018-06-30NZ$0.60 B44.49%
2017-06-30NZ$0.41 B115.84%
2016-06-30NZ$0.19 B-12.88%
2015-06-30NZ$0.22 B162.56%
2014-06-30NZ$84.9 M-38.26%
2013-06-30NZ$0.13 B-20.61%
2012-06-30NZ$0.17 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Supernus Pharmaceuticals
SUPN
NZ$0.48 B-16.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
NZ$0.29 B-48.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
NZ$3.54 B 510.77%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
NZ$0.55 B-3.67%๐Ÿ‡บ๐Ÿ‡ธ USA